FDA draft guidance may turn diversity in clinical trials from nice-to-have into a must-have

Listen to the article 6 min This audio is auto-generated. Please let us know if you have feedback. Supporting diversity in clinical trials and actually achieving it are two different issues. There is much agreement in pharma that including a broad swath of participants in clinical trials leads to better drugs and outcomes, but most … Read more